tirzepatide patent expiration us 🚨 Generic Versions of Mounjaro & Zepbound Move Closer as FDA Reviews First Applications The Food and Drug Administration (FDA) is reviewing the first applications for generic versions of Eli Lilly's How to Survive the GLP-1

Wegovy is prescribed to adults who: Have a BMI of 30 or higher (obesity), or Have a BMI of 27 or higher (overweight) and at least one weight-related condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol) 3

Wegovy affects gastric emptying and can cause gastrointestinal side effects such as nausea, vomiting, and delayed stomach emptying

Dermal fillers have become popular as new technology and methods have made them more effective

Together, they work at the cellular level to reduce oxidative stress, improve skin clarity, and protect against UV-induced pigmentation the perfect foundation for lasting radiance

The next chapter of the GLP-1 story wont just be written in labs or clinics